Tarsus Pharmaceuticals, Inc.
← Back to TARS Overview

Tarsus Pharmaceuticals, Inc. (TARS)

Revenue & Top-Line Growth

Latest Revenue

$162.1M

Financial Fundamentals

TARSQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.16B+6.8%+106.9%0.54B+129.0%
2025-12-310.15B+27.8%+128.4%0.45B+146.7%
2025-09-300.12B+15.6%+146.7%0.37B+182.4%
2025-06-300.10B+31.1%+151.5%0.30B+254.5%
2025-03-310.08B+18.0%+183.7%0.23B+449.0%
2024-12-310.07B+38.0%+407.9%0.18B+948.6%
2024-09-300.05B+17.9%+2471.8%0.13B+802.0%
2024-06-300.04B+47.8%0.08B+567.0%
2024-03-310.03B+111.2%+1004.6%0.04B+53.2%
2023-12-310.01B+598.9%+30.8%0.02B-32.4%
2023-09-300.00B0.01B-11.0%
2023-06-300.00B0.01B-28.1%
2023-03-310.00B-75.0%+363.8%0.03B+15.1%
2022-12-310.01B+2858.6%0.03B-54.7%
2022-09-300.00B0.02B-71.5%
2022-06-300.02B+2734.3%-30.6%0.02B-68.6%
2022-03-310.00B+59.5%-98.4%0.02B-27.8%
2021-12-310.00B-72.7%0.06B
2021-09-300.00B-94.4%0.06B
2021-06-300.02B-34.1%0.06B
2021-03-310.03B0.03B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B
2019-12-310.00B0.00B
2019-09-300.00B0.00B
2018-06-300.00B0.00B
2018-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.45B+146.7%
20240.18B+948.6%
20230.02B-32.4%
20220.03B-54.7%
20210.06B
20200.00B
20190.00B
20180.00B